July 5 (Reuters) - NEUROSEARCH A/S NEUR.CO :
* SAID ON TUESDAY SOLD REMAINING RIGHTS IN THE PRECLINICAL
AND CLINICAL ASSETS DIVESTED TO SANIONA DURING THE PERIOD
2012-2016
* IN FULL AND FINAL SETTLEMENT OF NEUROSEARCH'S REMAINING
RIGHTS IN THE DIVESTED PROGRAMS, WIL RECEIVE FROM SANIONA
ONE-TIME CASH PAYMENT OF DKK 5.5 MLN
* SANIONA WILL FULLY ASSUME NEUROSEARCH'S ROYALTY
OBLIGATIONS TO THIRD PARTIES REGARDING POTENTIAL NET SALES OF
PRODUCTS
* FOR 2017, NEUROSEARCH NOW EXPECTS AN OPERATING LOSS IN THE
RANGE OF DKK 2.3-3.3 MILLION, AGAINST PREVIOUSLY DKK 4.5-5.5
MILLION
Source text for Eikon: urn:newsml:reuters.com:*:nCSE6ZKT
Further company coverage: NEUR.CO
(Gdynia Newsroom)
((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))